Joachim Bischof

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Childhood Cancer

Top Venues

International journal of molecular sciences

Bioscience, biotechnology, and biochemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aileen Roth, Adrian Gihring, Joachim Bischof, Leiling Pan, Franz Oswald, Uwe Knippschild
CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes. Cancers 14 (5) (2022)
Aileen Roth, Adrian Gihring, Florian Göser, Christian Peifer, Uwe Knippschild, Joachim Bischof
Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example. Molecules (Basel, Switzerland) 26 (16) (2021)
Aileen Roth, Fabian Gärtner, Katja Mayer, Julian Beyrle, Irina König, Uwe Knippschild, Joachim Bischof
CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP. International journal of molecular sciences 22 (12) (2021)
Congxing Liu, Lydia Witt, Chiara Ianes, Joachim Bischof, Marie-Thérèse Bammert, Joana Baier, Stefan Kirschner, Doris Henne-Bruns, Pengfei Xu, Marko Kornmann, Christian Peifer, Uwe Knippschild
Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines. International journal of molecular sciences 20 (24) (2019)
Thomas Böhm, Zhigang Meng, Philipp Haas, Doris Henne-Bruns, Najma Rachidi, Uwe Knippschild, Joachim Bischof
The kinase domain of CK1δ can be phosphorylated by Chk1. Bioscience, biotechnology, and biochemistry 83 (9) (2019)